Home › Funds › Caligan Partners LP › ABVX
Caligan Partners LP position in ABVX
ABIVAX SA · Health Care
Caligan Partners LP reported holding 1,557,924 shares of ABVX (ABIVAX SA) in its Q2 2026 13F filing — a position valued at US$207.6M, representing 12.14% of its reported portfolio and ranking #2 among its reported holdings. Caligan Partners LP has disclosed ABVX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Caligan Partners LP's ABVX position evolved
Caligan Partners LP first disclosed a stake in ABVX in Q4 2024 at 752,167 shares (US$5.5M). The position peaked in Q2 2026 at 1,557,924 shares, worth US$207.6M. Across 7 filings, Caligan Partners LP increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,557,924 shares valued at US$207.6M — an increase of 96,000 shares quarter over quarter.. Notable position changes include a 69% increase in Q1 2025 (shares rose 22% over the following quarter), a 32% increase in Q2 2025 (shares rose 1010% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 752.17K | $5.51M | New |
| Q1 2025 | 1.27M | $7.93M | Add |
| Q2 2025 | 1.67M | $12.81M | Add |
| Q3 2025 | 1.45M | $123.27M | Reduce |
| Q4 2025 | 1.45M | $195.80M | Hold |
| Q1 2026 | 1.46M | $162.79M | Add |
| Q2 2026 | 1.56M | $207.61M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABVX and 13F data
ABVX (ABIVAX SA) is a Health Care company. 72 other funds we track also report a position in ABVX — the largest reported positions include TCG Crossover Management, LLC (US$800.6M), Helikon Investments Ltd (US$371.4M), Darwin Global Management, Ltd. (US$348.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABVX
- TCG Crossover Management, LLC 6.01M sh · $800.60M · Q2 2026
- Helikon Investments Ltd 2.79M sh · $371.41M · Q2 2026
- Darwin Global Management, Ltd. 3.62M sh · $348.22M · Q2 2026
- Vestal Point Capital, LP 2.35M sh · $313.09M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.31M sh · $174.55M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.13M sh · $150.92M · Q2 2026
- Logos Global Management LP 1.02M sh · $136.46M · Q2 2026
- Octagon Capital Advisors LP 993.00K sh · $132.33M · Q2 2026
- Eversept Partners, LP 913.88K sh · $121.78M · Q2 2026
- Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. 765.33K sh · $101.99M · Q2 2026
- Cormorant Asset Management, LP 675.00K sh · $89.95M · Q2 2026
- Boxer Capital Management, LLC 605.00K sh · $80.62M · Q2 2026
More on Caligan Partners LP
FAQ
How long has Caligan Partners LP held ABVX?
Caligan Partners LP has disclosed ABVX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is Caligan Partners LP's current position in ABVX?
As of Q2 2026, Caligan Partners LP holds 1.56M shares of ABVX (ABIVAX SA), valued at $207.61M, representing 12.14% of its reported portfolio and ranking #2.
Has Caligan Partners LP been buying or selling ABVX?
In the latest 13F filing (Q2 2026), Caligan Partners LP increased its position in ABVX. The position peaked in Q2 2026 at 1.56M shares.
Which other funds hold ABVX?
Other major institutional holders of ABVX include TCG Crossover Management, LLC, Helikon Investments Ltd, Darwin Global Management, Ltd., among 72 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.